Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Intravenous immunoglobulin industry 360º synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product trends
2.1.4 Application trends
2.1.5 Distribution channel trends
Chapter 3 Intravenous Immunoglobulin Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing prevalence of immunodeficiency disorders
3.2.1.2 Increasing geriatric population
3.2.1.3 Growing advances in plasma collection, fractionation, and purification technologies
3.2.1.4 Increasing healthcare expenditure for immunoglobulins
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of IVIG therapy
3.2.2.2 Potential adverse effects and allergic reactions
3.2.2.3 Scarcity of plasma donors
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By application
3.3.3 By distribution channel
3.4 COVID- 19 impact analysis
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategy dashboard, 2022
Chapter 5 Intravenous Immunoglobulin Market Size and Forecast, By Product (USD Million)
5.1 Key trends, by product
5.2 IgG
5.3 IgA
5.4 IgM
5.5 IgD
5.6 IgE
Chapter 6 Intravenous Immunoglobulin Market Size and Forecast, By Application (USD Million)
6.1 Key trends, by application
6.2 Hypogammaglobulinemia
6.3 Chronic Inflammatory demyelinating polyneuropathy (CIDP)
6.4 Immunodeficiency diseases
6.5 Myasthenia gravis
6.6 Multifocal motor neuropathy
6.7 Idiopathic thrombocytopenic purpura (ITP)
6.8 Inflammatory myopathies
6.9 Specific antibody deficiency
6.10 Guillain-Barre syndrome
6.11 Other applications
Chapter 7 Intravenous Immunoglobulin Market Size and Forecast, By Distribution Channel (USD Million)
7.1 Key trends, by distribution channel
7.2 Hospital pharmacy
7.3 Specialty pharmacy
7.4 Other distribution channels
Chapter 8 Intravenous Immunoglobulin Market Size and Forecast, By Region (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 Takeda Pharmaceutical Company Limited.
9.2 Grifols SA
9.3 CSL Behring
9.4 ADMA Biologics
9.5 Octapharma AG
9.6 Baxter International Inc.
9.7 LFB Biotechnologies
9.8 China Biologics Products Inc.
9.9 Kedrion Biopharma
9.10 Intas Pharmaceuticals
